1. Home
  2. CHEF vs BEAM Comparison

CHEF vs BEAM Comparison

Compare CHEF & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Chefs' Warehouse Inc.

CHEF

The Chefs' Warehouse Inc.

HOLD

Current Price

$59.55

Market Cap

2.6B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$24.07

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHEF
BEAM
Founded
1985
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
CHEF
BEAM
Price
$59.55
$24.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$70.33
$48.09
AVG Volume (30 Days)
404.5K
2.2M
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
55.09
N/A
EPS
1.73
N/A
Revenue
$4,040,541,000.00
$55,701,000.00
Revenue This Year
$10.22
N/A
Revenue Next Year
$7.10
$19.01
P/E Ratio
$35.48
N/A
Revenue Growth
8.88
N/A
52 Week Low
$43.83
$13.53
52 Week High
$68.94
$35.25

Technical Indicators

Market Signals
Indicator
CHEF
BEAM
Relative Strength Index (RSI) 48.33 52.36
Support Level $56.47 $20.23
Resistance Level $63.36 $25.56
Average True Range (ATR) 2.20 1.61
MACD 0.10 0.41
Stochastic Oscillator 44.78 72.11

Price Performance

Historical Comparison
CHEF
BEAM

About CHEF The Chefs' Warehouse Inc.

The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: